InsidersTradesSigma
Follow the 삼천당제약 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼천당제약 has published 5 public disclosures. The latest transaction was filed on 10 July 2023 (Purchase). Among the most active insiders: 윤대인. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samchundang Pharmaceutical是一家韩国制药公司，专注于药物的开发和制造。该公司在XKRX市场上市。